Pharmacology & ToxicologybioRxivPreprint
In Vivo Biocompatibility of ZIF-8 for Antigen Slow Release via Intranasal Administration
S. Kumari, T. S. Howlett, R. N. Ehrman…·J. J. Gassensmith
This study evaluates the in vivo biocompatibility of ZIF-8 for antigen slow release via intranasal administration, finding no significant adverse effects on blood serum proteins, lung function, or tissue morphology.
DOI 10.1101/2023.01.07.523104